GR
Grace Therapeutics, Inc. (GRCE)
NASDAQ·Healthcare·Biotechnology
$1.83
+2.81%
Mkt Cap $55.53M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$4.00
Range $4.00 – $4.00
Implied Upside
+118.6%
Consensus $4.00 vs current $1.83
NASDAQ·Healthcare·Biotechnology
$1.83
+2.81%
Mkt Cap $55.53M
No recent rating data.
Price Target (1 analysts)
$4.00
Range $4.00 – $4.00
+118.6%
Consensus $4.00 vs current $1.83